Trials / Active Not Recruiting
Active Not RecruitingNCT03796767
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer
Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer (SOAR)
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of Utah · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This phase II trial studies how well surgery and radiation therapy work in treating patients with prostate cancer that has come back or spread to other parts of the body. Radiation therapy uses high energy beams to kill tumor cells and shrink tumors. Surgical procedures, such as oligometastasectomy, may remove tumor cells that have spread to other parts of the body. Surgery and radiation therapy may work better in treating patients with prostate cancer that has come back or spread to other parts of the body.
Detailed description
PRIMARY OBJECTIVES: I. To assess response to treatment of oligometastatic disease. SECONDARY OBJECTIVES: I. To assess additional measurements of response to treatment of oligometastatic disease. II. To assess prostate-specific antigen (PSA) progression free-survival following treatment of oligometastatic disease. III. To assess time to disease recurrence following treatment of oligometastatic disease. IV. To assess time to initiation of antiandrogen therapy (ADT) for metastatic prostate cancer following treatment of oligometastatic disease. V. To assess the rate of undetectable PSA following treatment of oligometastatic disease in subjects who have previously undergone prostatectomy. VI. To assess safety. VII. To assess the impact of study treatment on change in quality of life over three years.
Conditions
- Recurrent Prostate Carcinoma
- Metastatic Malignant Neoplasm in the Bone
- Metastatic Malignant Neoplasm in the Lymph Nodes
- Oligometastasis
- Prostate Adenocarcinoma
- PSA Failure
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Hypofractionated Radiation Therapy | Undergo hypofractionated radiation therapy |
| RADIATION | Intensity-Modulated Radiation Therapy | Undergo IMRT |
| PROCEDURE | Metastasectomy | Undergo salvage oligometastasectomy |
| OTHER | Quality-of-Life Assessment | Ancillary studies |
| OTHER | Questionnaire Administration | Ancillary studies |
| RADIATION | Stereotactic Body Radiation Therapy | Undergo SBRT |
Timeline
- Start date
- 2019-09-09
- Primary completion
- 2024-02-13
- Completion
- 2026-06-30
- First posted
- 2019-01-08
- Last updated
- 2026-01-28
- Results posted
- 2025-10-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03796767. Inclusion in this directory is not an endorsement.